Perioperative treatment with phosphatidic acid inhibitor (Lisofylline) leads to prolonged survival of hearts in the guinea pig to rat xenotransplant model

Transplantation Proceedings

Volumn 28, Issue 2, 1996, Pages 738-739

  Valdivia, L A ^a   Murase, N ^a   Rao, A S ^a   Rice, G ^a   Singer, J W ^a   Sun, H ^a   Todo, S ^a   Pan, F ^a   Subbotin, V ^a   Fung, J J ^a   Starzl, T E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; LISOFYLLINE; METHYLPREDNISOLONE; PHOSPHATIDIC ACID; STEROID;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; GRAFT REJECTION; GRAFT SURVIVAL; GUINEA PIG; HEART TRANSPLANTATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; XENOTRANSPLANTATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, HETEROPHILE; COMPLEMENT C3; GRAFT SURVIVAL; GUINEA PIGS; HEART TRANSPLANTATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; INTRAOPERATIVE PERIOD; METHYLPREDNISOLONE; PENTOXIFYLLINE; PHOSPHATIDIC ACIDS; RATS; RATS, INBRED LEW; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029926716     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)